PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma
- 1 January 2014
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 132 (1) , 188-193
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Reproducibility of histological cell type in high-grade endometrial carcinomaLaboratory Investigation, 2013
- Histotype-Genotype Correlation in 36 High-grade Endometrial CarcinomasAmerican Journal of Surgical Pathology, 2013
- Poor Interobserver Reproducibility in the Diagnosis of High-grade Endometrial CarcinomaAmerican Journal of Surgical Pathology, 2013
- Integrated genomic characterization of endometrial carcinomaNature, 2013
- Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinomaProceedings of the National Academy of Sciences, 2013
- Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genesNature Genetics, 2012
- Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide AnalysesJNCI: Journal of the National Cancer Institute, 2012
- Use of mutation profiles to refine the classification of endometrial carcinomasThe Journal of Pathology, 2012
- Association of Low-Grade Endometrioid Carcinoma of the Uterus and Ovary With Undifferentiated Carcinoma: A New Type of Dedifferentiated Carcinoma?International Journal of Gynecological Pathology, 2006
- Endometrial cancerThe Lancet, 2005